The Cell Signaling 2019

Jul 19-20, 2019

New York, United States of America

Conference on The Cell Signaling 2019

LEXIS would like to extend our warmest invitation to you to participate in The Cell Signaling 2019 going to take place at New York, USA during September 19-20, 2019 which includes prompt keynote presentations, plenary talks, oral talks, poster presentations, and exhibitions. The main theme of the conference is “Traversing the Future of Cell Signaling”


Cell Signalling is a piece of any correspondence procedure that oversees essential exercises of cells and arranges all cell activities. The capacity of cells to see and accurately react to their microenvironment is the premise of advancement, tissue repair, and resistance, and also ordinary tissue homeostasis. Blunders in flagging connections and cell data handling are in charge of maladies, for example, tumor, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.

Traditional work in biology has focused on concentrate singular parts of cell signaling pathways. Frameworks science investigate encourages us to comprehend the hidden structure of cell signaling systems and how changes in these systems may influence the transmission and stream of data (flag transduction). Such systems are unpredictable frameworks in their association and may display various rising properties including bistability and ultrasensitivity. Examination of cell signaling systems requires a blend of test and hypothetical methodologies including the improvement and investigation of recreations and modeling. Long-range allostery is regularly a huge part of cell flagging occasions


Cell Signaling is to provide an opportunity to research scholars, delegates, and students to interact and share their experience and knowledge in technology application and will provide an excellent international forum for sharing knowledge and results. The aim of the Conference is to provide a platform to the researchers and practitioners from both academia as well as industry to meet the share cutting-edge development in the field. The scientific program will include overviews, state of the art lectures and controversial debates, interactive education sessions, B2B meetings, and round-table discussions apart from the conventional plenary sessions, featured symposia, breakout sessions and oral presentation sessions for abstracts. 

Market Analysis:

The cell signaling market is estimated to reach USD 3.51 Billion by 2022 from USD 2.53 Billion in 2017, at a CAGR of 6.8%. The term “cell signaling” is used to define the complex interactive system of signals that regulate and mediate various cellular responses in the human body.

Cell signaling is used to learn signaling pathways of cells in drug discovery and therapeutic development, to distinguish drug resistance patterns in cancerous cells. It also identifies the major signaling pathways impacted by specific drug treatments. Cell signaling pathways also called signal transduction pathways to act as connecting links between environmental stimuli and the corresponding cellular response. These signaling pathways mainly consist of proteins that can interact, move to specific locations, or be modified.

Growth in the medical supplies market is primarily driven by rising incidence of chronic diseases, and availability of funding for cell-based research activities. Other factors that are also positively affecting the growth of this market are technological advancements in cell-based research instruments and growth in life science and biopharmaceutical industries. Moral issues related to embryonic stem cell signaling research and the high cost of cell signaling systems are expected to hinder the growth of this market.

Based on the type, the cell signaling market is segmented into paracrine, autocrine, endocrine, juxtacrine, and other signaling types (neuronal and intracrine). The endocrine signaling segment is projected to account for the largest share of cell signaling market in 2017.

By product, the cell signaling market is segmented into consumables (reagents, assay kits, antibodies, and other consumables) and instruments. In 2017, the consumables segment is projected to account for the largest share of the cell signaling market.

Based on technology, the cell signaling market is segmented into microscopy, western blotting, immunohistochemistry (IHC), Flow Cytometry, enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and other technologies (immunofluorescence and immune precipitation). The microscopy segment is estimated to account for the largest share of cell signaling market in 2017.

Based on application, the cell signaling market is segmented into research applications (stem cell, immunology, cancer, and other research applications), and medical applications. The research applications segment is projected to account for the largest share of cell signaling market in 2017.

Cell Signaling Market, by Application

  • Research Applications

  • Medical Applications

In 2017, the medical supplies market is dominated by North America, followed by Europe. North America is expected to continue to dominate the market by 2022. Asia is estimated to witness the highest CAGR, centered at China, Japan, and India, during the forecast period.

The major players in the cell signaling market include QIAGEN N.V. (Netherlands), Beckman Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Tech Corporation (U.S.), Miltenyi Biotec (Germany), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), Cisbio Bioassays (France), Cell Biolabs, Inc. (U.S.), Full Moon Bio Systems, Inc. (U.S.), Tonbo Biosciences (U.S.), Bio Vision, Inc. (U.S.), Stress Marq Biosciences Inc. (U.S.), Ray Biotech, Inc. (U.S.), Rockland Immunochemicals Inc. (U.S.), Abeomics, Inc. (U.S.), BPS Bioscience, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), Sino Biological, Inc. (U.S.), and Santa Cruz Biotechnology, Inc. (U.S.).

Key Target Audience:

  • Cell signaling associations

  • Research & consulting firms

  • Distributors of cell signaling research products

  • Contract manufacturers of cell signaling consumables and instruments

  • Research institutes and clinical research organizations (CROs)

  • Venture capitalists

  • Government associations

Cell Signaling Market, by Type

  • Endocrine Signaling

  • Paracrine Signaling

  • Autocrine Signaling

  • Juxtacrine Signaling

  • Other Signaling Types

Cell Signaling Market, by Pathway

  • Akt

  • AMPK

  • ErbB/HER

  • Hedgehog (Hh)


  • NF-êB

  • Notch

  • Other Signaling Pathways

Cell Signaling Market, by Technology

  • Microscopy

  • Western Blotting

  • Flow Cytometry

  • Immunohistochemistry (IHC)


  • Mass Spectrometry

  • Other Technologies


Details of The Cell Signaling Conference 2019 in New York, USA:

Conference Name Place Date
The Cell Signaling 2019 New York, USA July 19-20,2019

Program Overview